Diversifying Selection in Human Papillomavirus Type 16 Lineages Based on Complete Genome Analyses
Open Access
- 1 June 2005
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 79 (11) , 7014-7023
- https://doi.org/10.1128/jvi.79.11.7014-7023.2005
Abstract
Human papillomavirus type 16 (HPV16) is the primary etiological agent of cervical cancer, the second most common cancer in women worldwide. Complete genomes of 12 isolates representing the major lineages of HPV16 were cloned and sequenced from cervicovaginal cells. The sequence variations within the open reading frames (ORFs) and noncoding regions were identified and compared with the HPV16R reference sequence (50). This whole-genome approach gives us unprecedented precision in detailing sequence-level changes that are under selection on a whole-viral-genome scale. Of 7,908 base pair nucleotide positions, 313 (4.0%) were variable. Within the 2,452 amino acids (aa) comprising 8 ORFs, 243 (9.9%) amino acid positions were variable. In order to investigate the molecular evolution of HPV16 variants, maximum likelihood models of codon substitution were used to identify lineages and amino acid sites under selective pressure. Five codon sites in the E5 (aa 48, 65) and E6 (aa 10, 14, 83) ORFs were demonstrated to be under diversifying selective pressure. The E5 ORF had the overall highest nonsynonymous/synonymous substitution rate (ω) ratio (M3 = 0.7965). The E2 gene had the next-highest ω ratio (M3 = 0.5611); however, no specific codons were under positive selection. These data indicate that the E6 and E5 ORFs are evolving under positive Darwinian selection and have done so in a relatively short time period. Whether response to selective pressure upon the E5 and E6 ORFs contributes to the biological success of HPV16, its specific biological niche, and/or its oncogenic potential remains to be established.Keywords
This publication has 93 references indexed in Scilit:
- Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysisBritish Journal of Cancer, 2003
- Human papillomavirus type‐16 variants in Quechua aboriginals from ArgentinaJournal of Medical Virology, 2003
- Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical CancerNew England Journal of Medicine, 2003
- Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysisBritish Journal of Cancer, 2003
- Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphismsThe Lancet, 1998
- The regulation mechanism of c-jun and junB by human papillomavirus type 16 E5 oncoproteinArchiv für die gesamte Virusforschung, 1996
- Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide PerspectiveJNCI Journal of the National Cancer Institute, 1995
- The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancerNature Medicine, 1995
- Identification of a naturally processed HLA A0201‐restricted viral peptide from cells expressing human papillomavirus type 16 E6 oncoproteinEuropean Journal of Immunology, 1994
- High-fidelity amplification using a thermostable DNA polymerase isolated from Pyrococcus furiosusGene, 1991